TY - JOUR
T1 - Role of adrenergic and cholinergic mediators in salivary phospholipids secretion
AU - Slomiany, Bronislaw L.
AU - Sengupta, Shipra
AU - Piotrowski, Elzbieta
AU - Lopez, Ramon A.
AU - Slomiany, Amalia
N1 - Funding Information: Supportedb y USPHS Grant No. DE05666-12f rom the National Institute of Dental Research and Grant No. AAO5858-10f rom the National Institute of Alcoholism and Alcohol Abuse, NIH.
PY - 1992/3/4
Y1 - 1992/3/4
N2 - The influence of adrenergic and cholinergic mediators on phospholipid secretion in rat sublingual salivary gland cells maintained in the presence of [3H]choline was investigated. The secretion of [3H]choline-containing phospholipids over 30 min period averaged 1.93% of the total cellular labeled phospholipids in the absence of any mediator, and was enhanced by β-adrenergic agonist, isoproterenol, to a greater extent than the cholinergic agonists, pilocarpine and carbachol. A 2.9-fold increase in phospholipid secretion occurred with isoproterenol, while pilocarpine and carbachol evoked only 1.3-fold increase. The effect of isoproterenol was inhibited by alprenolol and that of pilocarpine and carbachol by atropine. In contrast to pilocarpine and carbachol, the enhanced phospholipid secretion due to isoproterenol was accompanied by an increase in cAMP concentration. The secretion of phospholipids was also stimulated by dibutyryl-cAMP and the protein kinase C activator, phorbol myristate acetate, but not by 4α-phorbol 12,13-didecanoate which does not activate protein kinase C. Furthermore, the effects of dibutyrylcAMP and phorbol myristate acetate were additive. The phospholipids secreted in response to isoproterenol exhibited a 52% decrease in lysophosphatidylcholine, while those secreted in response to pilocarpine and carbachol showed a 21-23% lower content of phosphatidylcholine, and were enriched in lysophosphatidylcholine (2.6-2.8-fold) and sphingomyelin (1.5-1.6-fold). The results indicate that salivary phospholipid secretion remains mainly under β-adrenergic regulation, while the phospholipid makeup of the secretion is under cholinergic control.
AB - The influence of adrenergic and cholinergic mediators on phospholipid secretion in rat sublingual salivary gland cells maintained in the presence of [3H]choline was investigated. The secretion of [3H]choline-containing phospholipids over 30 min period averaged 1.93% of the total cellular labeled phospholipids in the absence of any mediator, and was enhanced by β-adrenergic agonist, isoproterenol, to a greater extent than the cholinergic agonists, pilocarpine and carbachol. A 2.9-fold increase in phospholipid secretion occurred with isoproterenol, while pilocarpine and carbachol evoked only 1.3-fold increase. The effect of isoproterenol was inhibited by alprenolol and that of pilocarpine and carbachol by atropine. In contrast to pilocarpine and carbachol, the enhanced phospholipid secretion due to isoproterenol was accompanied by an increase in cAMP concentration. The secretion of phospholipids was also stimulated by dibutyryl-cAMP and the protein kinase C activator, phorbol myristate acetate, but not by 4α-phorbol 12,13-didecanoate which does not activate protein kinase C. Furthermore, the effects of dibutyrylcAMP and phorbol myristate acetate were additive. The phospholipids secreted in response to isoproterenol exhibited a 52% decrease in lysophosphatidylcholine, while those secreted in response to pilocarpine and carbachol showed a 21-23% lower content of phosphatidylcholine, and were enriched in lysophosphatidylcholine (2.6-2.8-fold) and sphingomyelin (1.5-1.6-fold). The results indicate that salivary phospholipid secretion remains mainly under β-adrenergic regulation, while the phospholipid makeup of the secretion is under cholinergic control.
KW - Adrenergic
KW - Cholinergic mediation
KW - Salivary phospholipid
KW - Secretion
UR - http://www.scopus.com/inward/record.url?scp=0026596254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026596254&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/0005-2760(92)90094-C
DO - https://doi.org/10.1016/0005-2760(92)90094-C
M3 - Article
C2 - 1347459
SN - 1388-1981
VL - 1124
SP - 171
EP - 177
JO - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
JF - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
IS - 2
ER -